Evaluation of waning of SARS-CoV-2 vaccine–induced immunity: a systematic review and meta-analysis

F Menegale, M Manica, A Zardini, G Guzzetta… - JAMA network …, 2023 - jamanetwork.com
Importance Estimates of the rate of waning of vaccine effectiveness (VE) against COVID-19
are key to assess population levels of protection and future needs for booster doses to face …

COVID-19 vaccine booster dose acceptance: systematic review and meta-analysis

SA Abdelmoneim, M Sallam, DM Hafez… - Tropical medicine and …, 2022 - mdpi.com
The World Health Organization (WHO) recommended coronavirus disease 2019 (COVID-
19) booster dose vaccination after completing the primary vaccination series for …

Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a …

C Menni, AM Valdes, L Polidori, M Antonelli… - The Lancet, 2022 - thelancet.com
Summary Background The SARS-CoV-2 variant of concern, omicron, appears to be less
severe than delta. We aim to quantify the differences in symptom prevalence, risk of hospital …

Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis …

N Wu, K Joyal-Desmarais, PAB Ribeiro… - The Lancet …, 2023 - thelancet.com
Background Synthesising evidence on the long-term vaccine effectiveness of COVID-19
vaccines (BNT162b2 [Pfizer–BioNTech], mRNA-1273 [Moderna], ChAdOx1 nCoV-19 …

Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program

MD Brannock, RF Chew, AJ Preiss, EC Hadley… - Nature …, 2023 - nature.com
Long COVID, or complications arising from COVID-19 weeks after infection, has become a
central concern for public health experts. The United States National Institutes of Health …

Comorbidities and covid-19

P Adab, S Haroon, ME O'Hara, RE Jordan - bmj, 2022 - bmj.com
Over 530 million people worldwide are estimated to have had covid-19 by June 2022,
resulting in more than 6.3 million deaths. 1 Although most people have few symptoms or …

Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants

Y Liu, Z Wang, X Zhuang, S Zhang, Z Chen… - Nature …, 2023 - nature.com
A full understanding of the inactivated COVID-19 vaccine-mediated antibody responses to
SARS-CoV-2 circulating variants will inform vaccine effectiveness and vaccination …

SARS-CoV-2 humoral and cellular immunity following different combinations of vaccination and breakthrough infection

J Pušnik, WO Monzon-Posadas, J Zorn… - Nature …, 2023 - nature.com
The elicited anti-SARS-CoV-2 immunity is becoming increasingly complex with individuals
receiving a different number of vaccine doses paired with or without recovery from …

Comparison of the effectiveness and safety of heterologous booster doses with homologous booster doses for SARS-CoV-2 vaccines: a systematic review and meta …

J Deng, Y Ma, Q Liu, M Du, M Liu, J Liu - International Journal of …, 2022 - mdpi.com
As vaccine resources were distributed unevenly worldwide, sometimes there might have
been shortages or delays in vaccine supply; therefore, considering the use of …

Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines

R Fraser, A Orta-Resendiz, A Mazein… - Trends in molecular …, 2023 - cell.com
SARS-CoV-2 vaccination significantly reduces morbidity and mortality, but has less impact
on viral transmission rates, thus aiding viral evolution, and the longevity of vaccine-induced …